| Martin Vandort, | |
|
2314 Sassafras St, 2nd Fl, Erie, PA 16502-2721 | |
| (814) 456-6194 | |
| (814) 452-5777 |
| Full Name | Martin Vandort |
|---|---|
| Gender | Male |
| Speciality | Infectious Disease |
| Experience | 31 Years |
| Location | 2314 Sassafras St, Erie, Pennsylvania |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1225239445 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RI0200X | Internal Medicine - Infectious Disease | MD431739 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Saint Vincent Hospital | Erie, PA | Hospital |
| Williamsport Regional Medical Center | Williamsport, PA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| St Vincent Medical Education And Research Institute Inc | 3870405137 | 258 |
News Archive
A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.
In the July 10th issue of The New England Journal of Medicine, Dr. Basch calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.
An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 1b study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism, which is a frequent and serious complication of end-stage renal disease.
› Verified 1 days ago
| Entity Name | St Vincent Medical Education And Research Institute Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1902881477 PECOS PAC ID: 3870405137 Enrollment ID: O20031104000576 |
News Archive
A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.
In the July 10th issue of The New England Journal of Medicine, Dr. Basch calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.
An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 1b study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism, which is a frequent and serious complication of end-stage renal disease.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Martin Vandort, 2314 Sassafras St, 2nd Fl, Erie, PA 16502-2721 Ph: (814) 456-6194 | Martin Vandort, 2314 Sassafras St, 2nd Fl, Erie, PA 16502-2721 Ph: (814) 456-6194 |
News Archive
A new UCLA AIDS Institute study suggests that the use of social networking websites by homeless youth can lead to an increase in risky sexual behaviors. But interestingly, homeless kids who used these sites were also more likely to have been tested for sexually transmitted infections and to be better informed about preventing such infections and HIV.
In the July 10th issue of The New England Journal of Medicine, Dr. Basch calls for pharmaceutical manufacturers to collect rigorous information on how drugs impact symptoms and quality of life starting early in drug development, and for the U.S. Food and Drug Administration (FDA) to include this information in drug labels.
An advisory panel from the United States Food and Drug Administration (FDA) has recommended the approval of a novel epilepsy drug that is made up of ingredients from marijuana. The agency normally follows the recommendations of the advisory panels regarding approvals and rejections of applications of new drugs. The recommendation statement came yesterday (19th April 2018).
KAI Pharmaceuticals, Inc., a privately held drug discovery and development company, today announced enrollment of the first patients in a Phase 1b study of KAI-4169, a novel pharmaceutical agent being tested for the treatment of secondary hyperparathyroidism, which is a frequent and serious complication of end-stage renal disease.
› Verified 1 days ago
Bushra Rizvi, MD Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 300 State St Ste 103a, Suite 103a, Erie, PA 16507 Phone: 814-877-8540 | |
Debjit Saha, Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 201 State St, Erie, PA 16550 Phone: 814-877-4922 Fax: 814-877-3622 | |
Mr. Pradeep Dayanand, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 2315 Myrtle St Ste 190, Erie, PA 16502 Phone: 814-453-7767 Fax: 814-454-6667 | |
Dr. James Pawlak Iii, DO Infectious Disease Medicare: Medicare Enrolled Practice Location: 5515 Peach St, Erie, PA 16509 Phone: 814-864-4031 | |
Dr. Theresa J Fryer, M.D. Infectious Disease Medicare: Medicare Enrolled Practice Location: 3317 Liberty St, Erie, PA 16508 Phone: 814-868-8531 Fax: 814-866-1439 | |
Mohamad Khaled Sabeh, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 2315 Myrtle St Ste 190, Erie, PA 16502 Phone: 814-453-7767 Fax: 814-454-6667 | |
Dr. Edward C Clark, M.D. Infectious Disease Medicare: Accepting Medicare Assignments Practice Location: 311 W 24th St, Suite 402, Erie, PA 16502 Phone: 814-453-6687 Fax: 814-456-4676 |